The German giant is looking to develop new drugs for undisclosed eye diseases using Re-Vana’s extended-release injectable platform to supply drugs to the eye for months at a time.
The star of GSK’s Hengrui partnership is the COPD candidate HRS-9821, which will complement the pharma’s respiratory pipeline that’s anchored by the anti-asthma drug Nucala.
Brazilian authorities said the death was unlikely to have been caused by Elevidys and was instead more in line with severe infection exacerbated by immunosuppression.
President Donald Trump said he is considering sending rebate checks to Americans using revenue from tariff increases his administration is imposing on U.S. trading partners.
The Treasury Department is reportedly mulling plans for the IRS to eliminate its multilingual services, such as tax forms and assistance in languages other than English.